
According to Validea's guru fundamental report, LAM RESEARCH CORPORATION (LRCX) receives an 86% rating based on Warren Buffett's Patient Investor strategy, indicating strong interest due to the firm's long-term profitability, low debt, and reasonable valuation; the report highlights LRCX's strengths in earnings predictability, debt service, return on equity, free cash flow, use of retained earnings, share repurchase, initial rate of return, and expected return, while noting a failure in return on total capital.
Lam Research Corporation (LRCX), a large-cap growth stock within the Semiconductors industry, has received a favorable assessment from Validea's Patient Investor model, which is based on Warren Buffett's investment principles, scoring 86% and reflecting a 'strongly positive' sentiment with a specific ticker sentiment score of 0.75. This rating, signifying 'some interest' from the strategy which seeks firms with long-term, predictable profitability, low debt, and reasonable valuations, is supported by LRCX meeting several key criteria. These include Earnings Predictability, Debt Service, Return on Equity, Free Cash Flow generation, effective Use of Retained Earnings, active Share Repurchase programs, a positive Initial Rate of Return, and favorable Expected Return. However, the fundamental analysis also flags a specific weakness, as Lam Research fails the 'Return on Total Capital' criterion, which warrants consideration despite the otherwise strong fundamental profile and alignment with several tenets of value investing.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.65
Ticker Sentiment